Skip to search formSkip to main contentSkip to account menu

BC-105

Known as: BC 105, BC105 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Pizotyline

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
Comparative Trial of Serotonin Antagonists in the Management of Migraine
who were not diagnosed as definite migraine (group B) in fact showed the best response to ergotamine (Tables III and V). This was… 
1987
1987
[The serotoninergic component in the mechanism of the development of neurogenic damage to the stomach].
The involvement of the serotoninergic system in the development of neurogenic gastric lesions induced by the three-hour… 
1978
1978
Yohimbine-induced stimulus control in the rat.
Rats were first trained in a 2-lever operant test chamber using a fixed ratio 10 schedule of water reinforcement. Discrimination… 
1978
1978
Studies on the 5-HT receptor in vascular smooth muscle.
Changes in tension were monitored isometrically on spiral strips of freshly obtained bovine basilar arteries. Ergotamine (E… 
1975
1975
[Basic treatment of migraine. Value of pizotifen (BC105)].
1974
1974
[Therapeutic use of Sandomigran (BC-105)].
1973
1973
BC‐105 AND DESERIL IN MIGRAINE PROPHYLAXIS (A double‐blind study)
THE INTRODUCTION OF serotonin antagonists in the treatment of patients with migraine is a great step forward for the prophylactic… 
1973
1973
[BC-105 preparation in treatment of migraine].
1972
1972
Clinical study of orexigenic action of a new antiserotonin agent, BC-105, in patients with pulmonary tuberculosis.
1972
1972
[Sandomigran (BC-105) in treatment of migraine and Horton's headache].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)